Navigation Links
Oberthur Technologies XPon Offer
Date:4/23/2008

PARIS, April 23 /PRNewswire-FirstCall/ -- This press release is not and must not be, directly or indirectly, distributed or made public in Australia, Canada, Japan, South Africa or the United States of America. The Offer is not being made to persons in those jurisdictions or elsewhere where their participation requires further offer documents, filings or other measures in addition to those required by Swedish law. This is a translation of the original Swedish language press release. In the event of a dispute, the original Swedish language press release shall prevail.

98.7% of the Shares in XPonCard Group AB (publ) Tendered in the Offer or Acquired in the Market

On 19 February 2008, Oberthur Technologies S.A. ("Oberthur") announced a recommended cash offer (the "Offer") to acquire all shares in XPonCard Group AB (publ) ("XPonCard"). On 8 April 2008, Oberthur declared the Offer unconditional and extended the acceptance period until 18 April 2008.

A total of 38,239 shares, representing 0.9% of the shares and votes in XPonCard, have been tendered during the extension of the acceptance period. Consequently, a total of 3,889,604 shares in XPonCard, representing 86.7% of the shares and votes in XPonCard, have been tendered in the Offer. Up until and including 22 April 2008, Oberthur has also acquired in total 539,250 shares in the market, representing 12.0% of the shares and votes in XPonCard. Accordingly, following the expiration of the extended acceptance period and including the shares acquired in the market, Oberthur will own in aggregate 4,428,854 shares in XPonCard, representing 98.7% of the shares and votes in XPonCard.

Settlement in respect of shares tendered during the extension of the acceptance period is expected to commence on or about 30 April 2008. The Offer will not be extended further. However, Oberthur may acquire additional shares in XPonCard in the market.

As previously announced, Oberthur will initiate mandatory redemption of the remaining, not tendered, XPonCard shares in the near term, as well as act to have the XPonCard share delisted from OMX Nordic Exchange Stockholm.

Oberthur Technologies S.A.

For further information, please contact:

Oberthur Technologies:

Jean-Michel Guichot

Chief Financial Officer

Phone: +33-1-47-64-64-08

E-Mail: jm.guichot@oberthur.com

Stephanie Cau

Investor relations

Phone: +33-1-47-85-56-57

E-mail: s.cau@oberthurcs.com


'/>"/>
SOURCE Oberthur Technologies
Copyright©2008 PR Newswire.
All rights reserved

Related biology news :

1. Beijing Genomics Institute adds AB SOLiD system to its next generation sequencing technologies
2. Europe develops new technologies to boost health of livestock
3. The bombardier beetle, power venom and spray technologies
4. Atmel and Phoenix Technologies Collaborate to Create Next-generation Security Solutions for PCs
5. Phoenix Technologies and Atmel Collaborate to Create Next-Generation Security Solutions for PCs
6. e-SMART Technologies Continues Delivery of Its New Super SMART Card in South Korea
7. e-Smart(R) Technologies Delivers Its New Super Smart Card(TM) in South Korea.
8. Material Technologies Holds First Electrochemical Fatigue Sensor Training for Private Inspection Firms
9. e-Smart(R) Technologies, Inc., Announces Next Generation Superthin Polyimide Flexible Circuit Biometric Super Smart Card(TM) card, the i am(TM) Card.
10. e-Smart Technologies, Inc. Responds to Information Subpoenas From Securities & Exchange Commission
11. e-Smart Technologies Responds to Press Release Issued By IDsmart LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its quarter and year ended December 31, 2016. ... million compared to $6.9 million in the same quarter last ... $0.6 million compared to $2.6 million in the fourth quarter ... was $0.5 million, or $0.02 per diluted share, which compares ...
(Date:2/8/2017)... Feb. 7, 2017 The biometrics market ... the confluence of organizations, desires to better authenticate ... systems (password and challenge questions), biometrics is quickly ... systems. The market is driven by use cases, ... consumer and enterprise uses cases, with consumer-facing use ...
(Date:2/7/2017)... Minn. , Feb. 7, 2017   MedNet ... supports the entire spectrum of clinical research, is pleased ... iMedNet , its innovative, highly flexible and award ... iMedNet customers. iMedNet is a proven ... provides Electronic Data Capture (EDC), but also delivers an ...
Breaking Biology News(10 mins):
(Date:2/28/2017)... ... February 28, 2017 , ... Patient travel ... and expertise. Colpitts Clinical Trial Travel and Expense , a division of ... unique need within the biotechnology and pharmaceutical industries in the United States, Europe, ...
(Date:2/28/2017)... , ... February 28, 2017 , ... Over 8,000 recognized ... In a new educational webinar on March 7, DrugDev will gather international ... in this especially difficult area. , Webinar: Overcoming the Challenges of Rare Disease ...
(Date:2/28/2017)... Diego, California (PRWEB) , ... February 28, 2017 ... ... and supports high-growth, high-impact life science and biotechnology companies today announced it ... entrepreneurial communities, will be based out of Durham, NC and will begin work ...
(Date:2/28/2017)... RepliCel Life Sciences Inc. (OTCQB:REPCF) (TSXV:RP) (FRA:P6P2) ("RepliCel" or ... unique biologic products for pattern baldness and thinning hair, ... announced it has recently signed agreements with two European ... RepliCel to get the Company,s commercial-grade RCI-02 dermal injector ... ...
Breaking Biology Technology: